Pharma Reaserch Prod Co Ltd (214450) — Capital Reinvestment Ratio
Pharma Reaserch Prod Co Ltd (214450) has a Capital Reinvestment Ratio of 0.13x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩61.53 Billion) in capital expenditures (₩7.79 Billion). See Pharma Reaserch Prod Co Ltd balance sheet independence to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Pharma Reaserch Prod Co Ltd Capital Reinvestment Ratio (2015–2025)
This chart tracks Pharma Reaserch Prod Co Ltd's Capital Reinvestment Ratio across 11 annual periods. Check Pharma Reaserch Prod Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd (2015–2025)
Year-by-year Capital Reinvestment Ratio for Pharma Reaserch Prod Co Ltd from 2015 to 2025. For live market cap and broader valuation context, see Pharma Reaserch Prod Co Ltd (214450) market capitalisation.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.20x | ₩183.16 Billion | ₩35.78 Billion | ▼ -29.4% |
| 2024 | 0.28x | ₩139.88 Billion | ₩38.73 Billion | ▲ +36.2% |
| 2023 | 0.20x | ₩64.95 Billion | ₩13.20 Billion | ▼ -32.0% |
| 2022 | 0.30x | ₩59.40 Billion | ₩17.76 Billion | ▼ -5.5% |
| 2021 | 0.32x | ₩65.30 Billion | ₩20.64 Billion | ▼ -70.6% |
| 2020 | 1.07x | ₩32.39 Billion | ₩34.78 Billion | ▲ +115.9% |
| 2019 | 0.50x | ₩19.27 Billion | ₩9.59 Billion | ▼ -91.0% |
| 2018 | 5.50x | ₩5.20 Billion | ₩28.60 Billion | ▲ +516.2% |
| 2017 | 0.89x | ₩8.56 Billion | ₩7.63 Billion | ▲ +271.8% |
| 2016 | 0.24x | ₩8.16 Billion | ₩1.96 Billion | ▲ +730.2% |
| 2015 | 0.03x | ₩16.02 Billion | ₩462.99 Million | — |